Mitochondrial 2-hydroxyglutarate dehydrogenases modulate the cellular epitranscriptome
线粒体 2-羟基戊二酸脱氢酶调节细胞表观转录组
基本信息
- 批准号:10322194
- 负责人:
- 金额:$ 31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-01-01 至 2024-12-31
- 项目状态:已结题
- 来源:
- 关键词:Acetyl Coenzyme AAcetylationAgreementB-LymphocytesBiological ModelsBiological ProcessCell LineCellsChemicalsCysteineDNADNA MethylationDataDioxygenasesDistalEnzymesEpigenetic ProcessExerciseGene ExpressionGene Expression ProfileGenerationsGenesGenetic ModelsGenetic TranscriptionHexosaminesHistonesHomeostasisHumanHypermethylationIn VitroKnowledgeLinkLocationMediatingMessenger RNAMetabolismMethylationMethyltransferaseMitochondriaMitochondrial RNAMixed Function OxygenasesModelingModificationMutationNuclearO-GlcNAc transferaseOrganellesOutputOxidoreductasePathologyPathway interactionsPhysiologyPlayPost-Translational Protein ProcessingProductionProteinsRNARNA methylationReactive Oxygen SpeciesReporterResearchRoleS-AdenosylmethionineSignal TransductionStem Cell DevelopmentTestingTherapeuticTranscriptional ActivationTransgenic MiceWorkalpha ketoglutaratechromatin immunoprecipitationdemethylationepitranscriptomefield studyhistone demethylasehistone methylationhuman diseasein vitro Modelin vivoloss of functionmitochondrial metabolismmouse modelnoveloxidation
项目摘要
There is increasing recognition of mitochondria as signaling organelles. An important facet of this “adjunct”
mitochondrial function is epigenetic modulation, as exemplified by the generation of acetyl-CoA and S-
adenosylmethionine used in the acetylation and methylation, respectively, of DNA and histones. In addition,
alpha-ketoglutarate (αKG) and 2-hydroxyglutarate (2-HG), metabolites generated almost exclusively in the
mitochondria, are found to modulate the activity of αKG-dependent dioxygenases, including TET DNA
hydroxylases and histone demethylase (HDM), thus controlling DNA and histone methylation. Notably, our
group discovered that αKG activates and 2-HG inhibits FTO and ALKBH5, RNA demethylases that act on N6-
methyladenosine (m6A), a reversible chemical modification of mRNA (the epitranscriptome) that influences
gene expression. Similar to other epigenetic marks, RNA methylation is dynamically controlled and m6A
abundance influence various biological functions, while its misregulation associates with human diseases.
Considering that αKG/2-HG are generated mainly by intermediary mitochondrial metabolism, and that the
activity of RNA demethylases are modulated by these metabolites, it is reasonable to speculate that
mitochondria play an important role in the control of RNA methylation homeostasis. In particular, we postulate
that the mitochondrial enzymes D-2- and L-2-hydroxyglutarate dehydrogenase (D2HGDH and L2HGDH),
which catalyze the interconversion of 2-HG to αKG, are integral to the interplay between mitochondrial
metabolism and the control of RNA methylation. This hypothesis is supported by our earlier discovery that loss
of function D2HGDH mutations leads to decreased activity of the αKG-dependent TET and HDM enzymes. We
recently expanded on this concept by identifying upstream signals that regulate D2HGDH and L2HGDH
expression/activity. Using ChIP assays, inducible cell lines and a transgenic mouse model we discovered that
MYC transcriptionally activates D2HGDH and L2HGDH, and that in a D2/L2HGDH/αKG-dependent manner it
induces FTO and ALKBH5 function leading to RNA demethylation in vitro and in vivo. Remarkably, we found
that the MYC-D2/L2HGDH-αKG axis also promotes the nuclear accumulation of FTO and ALKBH5, in
association with enhanced O-GlcNAcylation, a post-translational modification executed by another
mitochondrial enzyme, O-GlcNAc transferase (OGT). Here, using multiple genetic models in vitro and in vivo,
we will test the hypothesis that a novel mitochondrial signaling axis, which includes MYC at the proximal point,
D2/L2HGDH and OGT at the center, and, distally, FTO/ALKBH5 activity, controls the cellular epitranscriptome.
Our specific aims are: 1) characterize the contribution of D2HGDH/L2HGDH and of intermediate metabolites to
the control of m6A levels, 2) determine the mechanistic basis for the increased O-GlcNAcylation mediated by
the MYC-D2/L2HGDH-αKG axis and its role in promoting RNA demethylation, 3) define a mitochondrial
metabolism-dependent methylRNA/gene expression signature in human cells.
越来越多的人认识到线粒体是信号细胞器。这个“辅词”的一个重要方面是
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ricardo C Aguiar其他文献
Ricardo C Aguiar的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ricardo C Aguiar', 18)}}的其他基金
Mitochondrial 2-hydroxyglutarate dehydrogenases modulate the cellular epitranscriptome
线粒体 2-羟基戊二酸脱氢酶调节细胞表观转录组
- 批准号:
10117575 - 财政年份:2021
- 资助金额:
$ 31万 - 项目类别:
Mitochondrial 2-hydroxyglutarate dehydrogenases modulate the cellular epitranscriptome
线粒体 2-羟基戊二酸脱氢酶调节细胞表观转录组
- 批准号:
10541234 - 财政年份:2021
- 资助金额:
$ 31万 - 项目类别:
Post-Translational Control of TET Function in Lymphoma
淋巴瘤 TET 功能的翻译后控制
- 批准号:
10251482 - 财政年份:2013
- 资助金额:
$ 31万 - 项目类别:
Post-Translational Control of TET Function in Lymphoma
淋巴瘤 TET 功能的翻译后控制
- 批准号:
10512054 - 财政年份:2013
- 资助金额:
$ 31万 - 项目类别:
Non-coding RNAs at the interface of aberrant NF-kB signals and lymphomagenesis
异常 NF-kB 信号与淋巴瘤发生界面的非编码 RNA
- 批准号:
8974297 - 财政年份:2013
- 资助金额:
$ 31万 - 项目类别:
Non-coding RNAs at the interface of aberrant NF-kB signals and lymphomagenesis
异常 NF-kB 信号与淋巴瘤发生界面的非编码 RNA
- 批准号:
8436704 - 财政年份:2013
- 资助金额:
$ 31万 - 项目类别:
相似海外基金
Investigating the functions of histone acetylation in genome organization and leukemogenesis
研究组蛋白乙酰化在基因组组织和白血病发生中的功能
- 批准号:
EP/Y000331/1 - 财政年份:2023
- 资助金额:
$ 31万 - 项目类别:
Research Grant
Gene Modulation of Acetylation Modifiers to Reveal Regulatory Links to Human Cardiac Electromechanics
乙酰化修饰剂的基因调节揭示与人类心脏机电的调节联系
- 批准号:
10677295 - 财政年份:2023
- 资助金额:
$ 31万 - 项目类别:
Novel roles of PDK2 in heart failure: Regulation of mitochondrial nuclear crosstalk via metabolic regulation and histone acetylation
PDK2 在心力衰竭中的新作用:通过代谢调节和组蛋白乙酰化调节线粒体核串扰
- 批准号:
10635599 - 财政年份:2023
- 资助金额:
$ 31万 - 项目类别:
Regulation of hepatic lysine N-acetylation by cysteine proximity due to alcohol toxicity
酒精毒性导致的半胱氨酸接近对肝脏赖氨酸 N-乙酰化的调节
- 批准号:
10752320 - 财政年份:2023
- 资助金额:
$ 31万 - 项目类别:
Histone Acetylation Regulates Microglial Innate Immune Memory
组蛋白乙酰化调节小胶质细胞先天免疫记忆
- 批准号:
478927 - 财政年份:2023
- 资助金额:
$ 31万 - 项目类别:
Operating Grants
Dysregulation of Histone Acetylation in Parkinson's Disease
帕金森病中组蛋白乙酰化的失调
- 批准号:
10855703 - 财政年份:2023
- 资助金额:
$ 31万 - 项目类别:
Obesity-related hypertension: the contribution of PPAR gamma acetylation and asprosin
肥胖相关高血压:PPAR γ 乙酰化和白脂素的贡献
- 批准号:
10654210 - 财政年份:2023
- 资助金额:
$ 31万 - 项目类别:
The role N-terminal acetylation in dilated cardiomyopathy and associated arrhythmia
N-末端乙酰化在扩张型心肌病和相关心律失常中的作用
- 批准号:
10733915 - 财政年份:2023
- 资助金额:
$ 31万 - 项目类别:
In vivo tracing of hepatic ethanol metabolism to histone acetylation: role of ACSS2 in alcohol-induced liver injury
肝脏乙醇代谢与组蛋白乙酰化的体内追踪:ACSS2 在酒精性肝损伤中的作用
- 批准号:
10667952 - 财政年份:2023
- 资助金额:
$ 31万 - 项目类别:
The function of TWIST1 acetylation in cell fate and tissue development
TWIST1 乙酰化在细胞命运和组织发育中的作用
- 批准号:
10726986 - 财政年份:2023
- 资助金额:
$ 31万 - 项目类别:














{{item.name}}会员




